Ont Health Technol Assess Ser. 2005;5(1):1-148. Epub 2005 Jan 1.
To conduct an evidence-based analysis of the effectiveness and cost-effectiveness of bariatric surgery.
Obesity is defined as a body mass index (BMI) of at last 30 kg/m(2).() Morbid obesity is defined as a BMI of at least 40 kg/m(2) or at least 35 kg/m(2) with comorbid conditions. Comorbid conditions associated with obesity include diabetes, hypertension, dyslipidemias, obstructive sleep apnea, weight-related arthropathies, and stress urinary incontinence. It is also associated with depression, and cancers of the breast, uterus, prostate, and colon, and is an independent risk factor for cardiovascular disease. Obesity is also associated with higher all-cause mortality at any age, even after adjusting for potential confounding factors like smoking. A person with a BMI of 30 kg/m(2) has about a 50% higher risk of dying than does someone with a healthy BMI. The risk more than doubles at a BMI of 35 kg/m(2). An expert estimated that about 160,000 people are morbidly obese in Ontario. In the United States, the prevalence of morbid obesity is 4.7% (1999-2000). In Ontario, the 2004 Chief Medical Officer of Health Report said that in 2003, almost one-half of Ontario adults were overweight (BMI 25-29.9 kg/m(2)) or obese (BMI ≥ 30 kg/m(2)). About 57% of Ontario men and 42% of Ontario women were overweight or obese. The proportion of the population that was overweight or obese increased gradually from 44% in 1990 to 49% in 2000, and it appears to have stabilized at 49% in 2003. The report also noted that the tendency to be overweight and obese increases with age up to 64 years. BMI should be used cautiously for people aged 65 years and older, because the "normal" range may begin at slightly above 18.5 kg/m(2) and extend into the "overweight" range. The Chief Medical Officer of Health cautioned that these data may underestimate the true extent of the problem, because they were based on self reports, and people tend to over-report their height and under-report their weight. The actual number of Ontario adults who are overweight or obese may be higher. Diet, exercise, and behavioural therapy are used to help people lose weight. The goals of behavioural therapy are to identify, monitor, and alter behaviour that does not help weight loss. Techniques include self-monitoring of eating habits and physical activity, stress management, stimulus control, problem solving, cognitive restructuring, contingency management, and identifying and using social support. Relapse, when people resume old, unhealthy behaviour and then regain the weight, can be problematic. Drugs (including gastrointestinal lipase inhibitors, serotonin norepinephrine reuptake inhibitors, and appetite suppressants) may be used if behavioural interventions fail. However, estimates of efficacy may be confounded by high rates of noncompliance, in part owing to the side effects of the drugs. In addition, the drugs have not been approved for indefinite use, despite the chronic nature of obesity.
Morbidly obese people may be eligible for bariatric surgery. Bariatric surgery for morbid obesity is considered an intervention of last resort for patients who have attempted first-line forms of medical management, such as diet, increased physical activity, behavioural modification, and drugs. There are various bariatric surgical procedures and several different variations for each of these procedures. The surgical interventions can be divided into 2 general types: malabsorptive (bypassing parts of the gastrointestinal tract to limit the absorption of food), and restrictive (decreasing the size of the stomach so that the patient is satiated with less food). All of these may be performed as either open surgery or laparoscopically. An example of a malabsorptive technique is Roux-en-Y gastric bypass (RYGB). Examples of restrictive techniques are vertical banded gastroplasty (VBG) and adjustable gastric banding (AGB). The Ontario Health Insurance Plan (OHIP) Schedule of Benefits for Physician Services includes fee code "S120 gastric bypass or partition, for morbid obesity" as an insured service. The term gastric bypass is a general term that encompasses a variety of surgical methods, all of which involve reconfiguring the digestive system. The term gastric bypass does not include AGB. The number of gastric bypass procedures funded and done in Ontario, and funded as actual out-of-country approvals,() is shown below. Number of Gastric Bypass Procedures by Fiscal Year: Ontario and Actual Out-of-Country (OOC) ApprovalsData from Provider Services, MOHLTCCourtesy of Provider Services, Ministry of Health and Long Term Care
The Medical Advisory Secretariat reviewed the literature to assess the effectiveness, safety, and cost-effectiveness of bariatric surgery to treat morbid obesity. It used its standard search strategy to retrieve international health technology assessments and English-language journal articles from selected databases. The interventions of interest were bariatric surgery and, for the controls, either optimal conventional management or another type of bariatric procedure. The outcomes of interest were improvement in comorbid conditions (e.g., diabetes, hypertension); short- and long-term weight loss; quality of life; adverse effects; and economic analysis data. The databases yielded 15 international health technology assessments or systematic reviews on bariatric surgery. Subsequently, the Medical Advisory Secretariat searched MEDLINE and EMBASE from April 2004 to December 2004, after the search cut-off date of April, 2004, for the most recent systematic reviews on bariatric surgery. Ten studies met the inclusion criteria. One of those 10 was the Swedish Obese Subjects study, which started as a registry and intervention study, and then published findings on people who had been enrolled for at least 2 years or at least 10 years. In addition to the literature review of economic analysis data, the Medical Advisory Secretariat also did an Ontario-based economic analysis.
Bariatric surgery generally is effective for sustained weight loss of about 16% for people with BMIs of at least 40 kg/m(2) or at least 35 kg/m(2) with comorbid conditions (including diabetes, high lipid levels, and hypertension). It also is effective at resolving the associated comorbid conditions. This conclusion is largely based on level 3a evidence from the prospectively designed Swedish Obese Subjects study, which recently published 10-year outcomes for patients who had bariatric surgery compared with patients who received nonsurgical treatment. (1)Regarding specific procedures, there is evidence that malabsorptive techniques are better than other banding techniques for weight loss and resolution of comorbid illnesses. However, there are no published prospective, long-term, direct comparisons of these techniques available.Surgery for morbid obesity is considered an intervention of last resort for patients who have attempted first-line forms of medical management, such as diet, increased physical activity, behavioural modification, and drugs. In the absence of direct comparisons of active nonsurgical intervention via caloric restriction with bariatric techniques, the following observations are made:A recent systematic review examining the efficacy of major commercial and organized self-help weight loss programs in the United States concluded that the evidence to support the use of such programs was suboptimal, except for one trial on Weight Watchers. Furthermore, the programs were associated with high costs, attrition rates, and probability of regaining at least 50% of the lost weight in 1 to 2 years. (2)A recent randomized controlled trial reported 1-year outcomes comparing weight loss and metabolic changes in severely obese patients assigned to either a low-carbohydrate diet or a conventional weight loss diet. At 1 year, weight loss was similar for patients in each group (mean, 2-5 kg). There was a favourable effect on triglyceride levels and glycemic control in the low-carbohydrate diet group. (3)A decision-analysis model showed bariatric surgery results in increased life expectancy in morbidly obese patients when compared to diet and exercise. (4)A cost-effectiveness model showed bariatric surgery is cost-effective relative to nonsurgical management. (5)Extrapolating from 2003 data from the United States, Ontario would likely need to do 3,500 bariatric surgeries per year. It currently does 508 per year, including out-of-country surgeries.
对减肥手术的有效性和成本效益进行循证分析。
肥胖定义为体重指数(BMI)至少为30kg/m²。病态肥胖定义为BMI至少为40kg/m²或BMI至少为35kg/m²且伴有合并症。与肥胖相关的合并症包括糖尿病、高血压、血脂异常、阻塞性睡眠呼吸暂停、与体重相关的关节病以及压力性尿失禁。它还与抑郁症以及乳腺癌、子宫癌、前列腺癌和结肠癌有关,并且是心血管疾病的独立危险因素。肥胖在任何年龄段都与较高的全因死亡率相关,即使在调整了吸烟等潜在混杂因素之后也是如此。BMI为30kg/m²的人死亡风险比BMI正常的人高约50%。BMI为35kg/m²时,风险会增加一倍多。一位专家估计,安大略省约有16万人患有病态肥胖。在美国,病态肥胖的患病率为4.7%(1999 - 2000年)。根据安大略省2004年首席医疗官的报告,2003年,几乎一半的安大略省成年人超重(BMI 25 - 29.9kg/m²)或肥胖(BMI≥30kg/m²)。约57%的安大略省男性和42%的安大略省女性超重或肥胖。超重或肥胖人口的比例从1990年的44%逐渐增加到2000年的49%,2003年似乎稳定在49%。该报告还指出,超重和肥胖的趋势在64岁之前随年龄增长而增加。对于65岁及以上的人,应谨慎使用BMI,因为“正常”范围可能从略高于18.5kg/m²开始,并延伸到“超重”范围。首席医疗官警告说,这些数据可能低估了问题的真实程度,因为它们基于自我报告,而且人们往往会高估自己的身高并低估体重。安大略省超重或肥胖的成年人实际数量可能更高。饮食、运动和行为疗法用于帮助人们减肥。行为疗法的目标是识别、监测和改变不利于减肥的行为。技术包括自我监测饮食习惯和身体活动、压力管理、刺激控制、问题解决、认知重构、应急管理以及识别和利用社会支持。复发是指人们恢复旧的不健康行为然后重新增重,这可能会带来问题。如果行为干预失败,可以使用药物(包括胃肠道脂肪酶抑制剂、血清素去甲肾上腺素再摄取抑制剂和食欲抑制剂)。然而,由于高不依从率,部分原因是药物的副作用,疗效估计可能会受到混淆。此外,尽管肥胖具有慢性性质,但这些药物尚未被批准长期使用。
病态肥胖者可能符合减肥手术的条件。对于尝试过一线医疗管理形式(如饮食、增加身体活动、行为改变和药物)的患者,病态肥胖的减肥手术被视为最后手段的干预措施。有各种减肥手术程序,并且每个程序都有几种不同的变体。手术干预可分为两大类:吸收不良型(绕过部分胃肠道以限制食物吸收)和限制型(减小胃的大小,使患者用较少的食物就感到饱足)。所有这些手术都可以通过开放手术或腹腔镜手术进行。吸收不良技术的一个例子是Roux - en - Y胃旁路术(RYGB)。限制技术的例子有垂直束带胃成形术(VBG)和可调节胃束带术(AGB)。安大略省医疗保险计划(OHIP)医生服务福利表将收费代码“S120胃旁路术或分隔术,用于病态肥胖”列为保险服务。胃旁路术这个术语是一个通用术语,涵盖了多种手术方法,所有这些方法都涉及重新配置消化系统。胃旁路术这个术语不包括AGB。以下显示了安大略省资助并实施的胃旁路手术程序数量,以及作为实际国外批准资助的数量。按财政年度划分的胃旁路手术程序数量:安大略省和实际国外(OOC)批准情况数据来自提供者服务,MOHLTCCourtesy of Provider Services,Ministry of Health and Long Term Care
医学咨询秘书处审查了文献,以评估减肥手术治疗病态肥胖的有效性、安全性和成本效益。它使用其标准搜索策略从选定的数据库中检索国际卫生技术评估和英文期刊文章。感兴趣的干预措施是减肥手术,作为对照的是最佳常规管理或另一种减肥手术程序。感兴趣的结果是合并症(如糖尿病、高血压)的改善;短期和长期体重减轻;生活质量;不良反应;以及经济分析数据。这些数据库产生了15项关于减肥手术的国际卫生技术评估或系统综述。随后,医学咨询秘书处在2004年4月搜索截止日期之后(2004年4月至12月)搜索了MEDLINE和EMBASE,以获取关于减肥手术的最新系统综述。有10项研究符合纳入标准。这10项研究中的一项是瑞典肥胖受试者研究,该研究最初是一项登记和干预研究,然后发表了对已登记至少2年或至少10年的人的研究结果。除了对经济分析数据的文献综述外,医学咨询秘书处还进行了一项基于安大略省的经济分析。
减肥手术通常对于BMI至少为40kg/m²或BMI至少为35kg/m²且伴有合并症(包括糖尿病、高血脂和高血压)的人持续减重约16%是有效的。它对于解决相关合并症也有效。这一结论主要基于前瞻性设计的瑞典肥胖受试者研究的3a级证据,该研究最近公布了接受减肥手术的患者与接受非手术治疗的患者的10年结果。(1)关于具体手术程序,有证据表明吸收不良技术在减重和解决合并症方面优于其他束带技术。然而,目前尚无已发表的对这些技术的前瞻性、长期、直接比较。对于尝试过一线医疗管理形式(如饮食、增加身体活动、行为改变和药物)的患者,病态肥胖的减肥手术被视为最后手段的干预措施。在缺乏通过热量限制进行的积极非手术干预与减肥手术技术的直接比较的情况下,得出以下观察结果:最近一项对美国主要商业和有组织的自助减肥计划疗效的系统综述得出结论,支持使用此类计划的证据并不理想,除了一项关于慧俪轻体的试验。此外,这些计划成本高、流失率高,并且在1至2年内至少有50%的减重会反弹。(2)最近一项随机对照试验报告了1年的结果,比较了分配到低碳水化合物饮食或传统减肥饮食的严重肥胖患者的体重减轻和代谢变化。1年后,每组患者的体重减轻相似(平均2 - 5kg)。低碳水化合物饮食组对甘油三酯水平和血糖控制有有利影响。(3)一个决策分析模型表明,与饮食和运动相比,减肥手术可提高病态肥胖患者的预期寿命。(4)一个成本效益模型表明,相对于非手术管理,减肥手术具有成本效益。(5)根据2003年美国的数据推断,安大略省每年可能需要进行3500例减肥手术。目前每年进行508例,包括国外手术。